These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3055221)

  • 1. Disposition of xenobiotics: species differences.
    Rozman K
    Toxicol Pathol; 1988; 16(2):123-9. PubMed ID: 3055221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the disposition and metabolism of sulfinpyrazone.
    Dieterle W; Faigle JW
    Xenobiotica; 1981 Aug; 11(8):559-68. PubMed ID: 7303725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of [14C]-benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion.
    Waldmeier F; Schmid K
    Arzneimittelforschung; 1989 Jan; 39(1):62-7. PubMed ID: 2719745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of atenolol in animals.
    Reeves PR; Barnfield DJ; Longshaw S; McIntosh DA; Winrow MJ
    Xenobiotica; 1978 May; 8(5):305-11. PubMed ID: 96616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man.
    Balant LP; Wermeille M; Griffiths LA
    Q Rev Drug Metab Drug Interact; 1984; 5(1):1-24. PubMed ID: 6397783
    [No Abstract]   [Full Text] [Related]  

  • 12. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic biotransformation in livestock: comparison to other species commonly used in toxicity testing.
    Watkins JB; Klaassen CD
    J Anim Sci; 1986 Sep; 63(3):933-42. PubMed ID: 3759720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism studies of xenobiotics in the environment: fundamentals for safety assessment.
    Miyamoto J
    J Toxicol Sci; 1988 Nov; 13(4):221-46. PubMed ID: 3149680
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption and disposition of oxarbazole in man and laboratory animals.
    Benziger D; Dorrbecker S; Goehl T; Edelson J
    Drug Metab Dispos; 1978; 6(1):8-15. PubMed ID: 23278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
    Goldaniga GC; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals.
    Chen IW; Dorley JM; Ramjit HG; Pitzenberger SM; Lin JH
    Drug Metab Dispos; 1992; 20(3):390-5. PubMed ID: 1355713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)].
    Keck G
    Toxicol Eur Res; 1981 Jul; 3(4):207-15. PubMed ID: 7302948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
    Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
    Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D
    Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.